Neoplasms

Digestive System Diseases

All Conditions

Liver Neoplasms

Gastrointestinal Neoplasms

Digestive System Neoplasms

Gastrointestinal Diseases

Liver Diseases

Hematinics

All Drugs and Chemicals

Liver Extracts

Patients undergo Liver partition and portal vein ligation to induce hypertrophy of the future liver remnant

Patient undergo portal vein embolization or ligation

Associating liver partition and portal vein ligation for staged hepatectomy

Portal vein embolization or ligation

This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion (PVO) works in treating patients with liver cancer. Both treatments are types of 2-stage hepatectomies for removing liver cancer. ALPPS may be more effective than PVO in patients whose disease would traditionally be considered inoperable.

* Trial with surgical intervention

ALLPS VERSUS PVO Randomized Controlled Trial

ASSOCIATING LIVER PARTITION WITH PORTAL VEIN LIGATION FOR STAGED HEPATECTOMY (ALPPS) Versus Conventional Portal Vein Occlusion (PVO) for Resection of Liver Tumors Unresectable in One Step - a Randomized Controlled Trial

University of Zurich

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
ALLPS VERSUS PVO Randomized Controlled Trial	NCT01775267	Liver Tumors No...	Associating liv... Portal vein emb...	18 Years -	University of Zurich
ALLPS VERSUS PVO Randomized Controlled Trial	NCT01775267	Liver Tumors No...	Associating liv... Portal vein emb...	18 Years -	University of Zurich

Spots Global Cancer Trial Database for portal vein embolization or ligation